Biotech Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib July 13, 2023
Biotech Pharming Group to report second quarter and first half 2023 financial results on August 3 July 13, 2023
Biotech P-Cure, in Cooperation with Hadassah Medical Center, Completes Treatment Of First Patient Using World’s Most Compact, Patient Centric, Proton Therapy System June 26, 2023
Biotech Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 June 26, 2023
Biotech Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing June 26, 2023
Biotech Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 June 26, 2023
Biotech AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need April 8, 2023